(600351)"Yabao Pharmaceutical Group Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600351 · · 12 pages · Chinese
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Yabao Pharmaceutical
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress of Capital Reduction of a Controlled Subsidiary Following the Conversion of Capital Reserve into Registered Capital and Completion of Industrial and Commercial Registration Changes
- (600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Share Pledge Repurchase Transaction by Controlling Shareholder
- Announcement on Initial Repurchase of Shares through Call Auction
- Announcement on Adjustment of Upper Limit of Share Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical